Salesforce.com: Analysts' New Ratings

Editor's Note: Green and red arrows refer to intraday stock price movement.

NEW YORK ( TheStreet) -- CHANGE IN RATINGS

Abbott Laboratories ( ABT) rated new Hold at Deutsche. $53 price target. Sales of the company's lead drug, Humira, could be slowing.

Cleco ( CNL) downgraded at Wells Fargo from Outperform to Market Perform, Wells Fargo said. Valuation call.

Salesforce.com ( CRM) upgraded at FBR from Market Perform to Outperform, FBR Capital Markets said. $170 price target. Diversification efforts are gaining traction.

IntercontinentalExchange ( ICE) upgraded at KBW from Market Perform to Outperform, Keefe, Bruyette & Woods said. $147 price target.

Travelzoo ( TZOO) downgraded at Benchmark Company from Buy to Hold. Valuation call, based on a $66 price target.

End of report.

This article was written by a staff member of TheStreet.

More from Stocks

Danica Patrick's Final Race at 2018 Indianapolis 500: What She Thinks About Cars

Danica Patrick's Final Race at 2018 Indianapolis 500: What She Thinks About Cars

Why The FANG Stocks' Dominance May Not Be So Bad For The Market

Why The FANG Stocks' Dominance May Not Be So Bad For The Market

At End of May, Investors Signalling They May Stay Away

At End of May, Investors Signalling They May Stay Away

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

Neel Kashkari: The Heart of Our Financial System Is More Radioactive Than Ever

Neel Kashkari: The Heart of Our Financial System Is More Radioactive Than Ever